Over the past few years, we have seen a major increase in the consolidation of smaller central IRBs into larger organizations. Where there used to be a couple dozen independent… Read more

DaVita Clinical Research sites completed over 45,000 research related patient visits in 2018.  Our sites have worked with more than 70 sponsors and have learned the pros and cons of… Read more

After a successful and energetic investigator meeting, your highly anticipated clinical trial locomotive is clicking on all cylinders. Enrollment is ahead of schedule, you’re way under budget and ahead of… Read more

Anyone travelling on a long highway after 3 cups of coffee becomes really aware of their kidneys very quickly. But, besides getting rid of excess water, the kidney has other… Read more

Risk Based Monitoring (RBM) is a clinical trial-monitoring method that was developed to fulfil regulatory requirements but moves away from 100% source data verification (SDV) of patient data. RBM, in… Read more

Clinical research provides doctors important information on how to effectively treat patients, and is what makes the development of new medicines, new procedures and new tools possible. Clinical research allows… Read more

It’s 5:30 in the morning and I’m walking into a dialysis center in the suburbs of the Twin Cities. Who would have thought this is what I would be doing… Read more

Like many other site organizations, DaVita Clinical Research has struggled with defining ourselves within an industry that holds firm to their acronyms.   CRO, or contract research organization, has been able… Read more

The Guideline for Good Clinical Practice (GCP) is a set of guidelines written by the International Council for Harmonization of Technical Requirements for Pharmaceuticals for Human Use (ICH).  These guidelines… Read more

  The DaVita Clinical Research (DCR) Biorepository Grant Program (BioReG) was formed support precision-based medicine innovation in nephrology. To see an update of the BioReG Gran Program, please click the… Read more